Waage Christian, Director at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 300 shares at $9.73 ($3K) on 2021-12-21, disclosed to the SEC on 2021-12-23.
Scheduled sale ($3k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GOSS | BUY | 2022-07-15 | $50K | — | Filing → |
| GOSS | SELL | 2022-03-24 | $191K | — | Filing → |
| HRTX | SELL | 2021-09-23 | $4K | — | Filing → |